|
2024-10-08 |
2024-10-07 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
Officer
|
5,409
-9.7%
11.03
USD 59,661
|
5,409
-9.7%
|
11.03
|
USD 59,661
|
|
|
2024-09-10 |
2024-09-09 |
PS
Planned sale
|
Pedersen Leif E
PRESIDENT, CHIEF COMMERCAL OFF
Officer
|
51,224
-33.9%
11.29
USD 578,319
|
51,224
-33.9%
|
11.29
|
USD 578,319
|
|
|
2024-04-04 |
2024-04-02 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
Officer
|
422
-0.8%
17.77
USD 7,499
|
422
-0.8%
|
17.77
|
USD 7,499
|
|
|
2024-04-04 |
2024-04-02 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
Officer
|
4,740
-8.6%
16.77
USD 79,490
|
4,740
-8.6%
|
16.77
|
USD 79,490
|
|
|
2024-04-04 |
2024-04-02 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
Officer
|
328
-0.6%
17.67
USD 5,796
|
328
-0.6%
|
17.67
|
USD 5,796
|
|
|
2024-04-04 |
2024-04-02 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
Officer
|
3,024
-5.2%
16.75
USD 50,652
|
3,024
-5.2%
|
16.75
|
USD 50,652
|
|
|
2024-04-04 |
2024-04-02 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
Officer
|
649
-1.1%
17.72
USD 11,500
|
649
-1.1%
|
17.72
|
USD 11,500
|
|
|
2024-04-04 |
2024-04-02 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
Officer
|
5,264
-8.2%
16.76
USD 88,225
|
5,264
-8.2%
|
16.76
|
USD 88,225
|
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
3,000
-1.7%
18.00
USD 54,000
|
3,000
-1.7%
|
18.00
|
USD 54,000
|
|
|
2024-03-05 |
2024-03-04 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
3,000
-1.8%
18.28
USD 54,840
|
3,000
-1.8%
|
18.28
|
USD 54,840
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, DRUG DEV SOLUTIONS
Officer
|
5,000
-8.3%
18.00
USD 90,000
|
5,000
-8.3%
|
18.00
|
USD 90,000
|
|
|
2024-02-14 |
2024-02-12 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
6,000
-3.5%
18.00
USD 108,000
|
6,000
-3.5%
|
18.00
|
USD 108,000
|
|
|
2023-12-27 |
2023-12-26 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
6,000
-3.4%
18.00
USD 108,000
|
6,000
-3.4%
|
18.00
|
USD 108,000
|
|
|
2023-09-12 |
2023-09-11 |
PS
Planned sale
|
Pedersen Leif E
PRESIDENT, CHIEF COMMERCAL OFF
Officer
|
51,224
-28.4%
14.60
USD 747,870
|
51,224
-28.4%
|
14.60
|
USD 747,870
|
|
|
2023-08-23 |
2023-08-22 |
B
Purchase
|
BROSHY ERAN
Non-Executive Director
|
4,807
+50.3%
15.80
USD 75,951
|
4,807
+50.3%
|
15.80
|
USD 75,951
|
|
|
2023-08-23 |
2023-08-21 |
B
Purchase
|
BROSHY ERAN
Non-Executive Director
|
193
+2.1%
16.10
USD 3,107
|
193
+2.1%
|
16.10
|
USD 3,107
|
|
|
2023-06-06 |
2023-06-05 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, INTEGRATED DRUG DEV
Officer
|
19,104
-24.2%
21.55
USD 411,691
|
19,104
-24.2%
|
21.55
|
USD 411,691
|
|
|
2023-05-15 |
2023-05-11 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
5,000
-2.7%
20.82
USD 104,100
|
5,000
-2.7%
|
20.82
|
USD 104,100
|
|
|
2023-04-17 |
2023-04-14 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
5,000
-2.7%
23.66
USD 118,300
|
5,000
-2.7%
|
23.66
|
USD 118,300
|
|
|
2023-03-07 |
2023-03-06 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
10,000
-5.1%
21.45
USD 214,500
|
10,000
-5.1%
|
21.45
|
USD 214,500
|
|
|
2023-02-03 |
2023-02-02 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
15,000
-7.2%
20.00
USD 300,000
|
15,000
-7.2%
|
20.00
|
USD 300,000
|
|
|
2022-12-12 |
2022-12-08 |
S
Sale
|
EQT Avatar Parent L.P.
Large shareholder
|
29,954,521
-100.0%
15.00
USD 449,317,815
|
29,954,521
-100.0%
|
15.00
|
USD 449,317,815
|
|
|
2022-11-23 |
2022-11-22 |
PS
Planned sale
|
Pedersen Leif E
PRESIDENT, SOFTWARE
Officer
|
51,223
-22.6%
15.55
USD 796,518
|
51,223
-22.6%
|
15.55
|
USD 796,518
|
|
|
2022-11-16 |
2022-11-15 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
245,793
-27.1%
15.57
USD 3,826,997
|
245,793
-27.1%
|
15.57
|
USD 3,826,997
|
|
|
2022-11-16 |
2022-11-14 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
4,207
-0.5%
15.27
USD 64,241
|
4,207
-0.5%
|
15.27
|
USD 64,241
|
|
|
2022-11-15 |
2022-11-14 |
S
Sale
|
WALSH MATTHEW M
Non-Executive Director
|
12,059
-6.7%
14.74
USD 177,750
|
12,059
-6.7%
|
14.74
|
USD 177,750
|
|
|
2022-11-14 |
2022-11-09 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, INTEGRATED DRUG DEV
Officer
|
2,387
-3.1%
13.48
USD 32,177
|
2,387
-3.1%
|
13.48
|
USD 32,177
|
|
|
2022-08-23 |
2022-08-19 |
B
Purchase
|
McLean Stephen M.
Non-Executive Director
|
20,000
+90.9%
16.32
USD 326,400
|
20,000
+90.9%
|
16.32
|
USD 326,400
|
|
|
2022-08-18 |
2022-08-17 |
B
Purchase
|
Schemick Michael Andrew
CHIEF FINANCIAL OFFICER
Officer
|
25,000
+5.1%
16.64
USD 416,000
|
25,000
+5.1%
|
16.64
|
USD 416,000
|
|
|
2022-08-18 |
2022-08-16 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, INTEGRATED DRUG DEV
Officer
|
10,000
-11.3%
17.71
USD 177,100
|
10,000
-11.3%
|
17.71
|
USD 177,100
|
|
|
2022-08-17 |
2022-08-16 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
182,475
-16.7%
17.38
USD 3,171,416
|
182,475
-16.7%
|
17.38
|
USD 3,171,416
|
|
|
2022-08-17 |
2022-08-16 |
S
Sale
|
EQT Avatar Parent L.P.
Large shareholder
|
6,004,418
-16.7%
17.38
USD 104,356,785
|
6,004,418
-16.7%
|
17.38
|
USD 104,356,785
|
|
|
2022-06-09 |
2022-06-08 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, INTEGRATED DRUG DEV
Officer
|
10,000
-10.2%
19.16
USD 191,600
|
10,000
-10.2%
|
19.16
|
USD 191,600
|
|
|
2022-06-03 |
2022-06-02 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
50,000
-4.4%
19.52
USD 976,000
|
50,000
-4.4%
|
19.52
|
USD 976,000
|
|
|
2022-06-03 |
2022-06-02 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
100,000
-8.0%
19.59
USD 1,959,000
|
100,000
-8.0%
|
19.59
|
USD 1,959,000
|
|
|
2022-06-03 |
2022-06-02 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
100,000
-7.4%
19.55
USD 1,955,000
|
100,000
-7.4%
|
19.55
|
USD 1,955,000
|
|
|
2022-06-01 |
2022-05-31 |
S
Sale
|
EQT Avatar Parent L.P.
Large shareholder
|
1,500,000
-4.0%
19.00
USD 28,500,000
|
1,500,000
-4.0%
|
19.00
|
USD 28,500,000
|
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
SMITH PATRICK F
PRESIDENT, INTEGRATED DRUG DEV
Officer
|
3,352
-3.3%
22.29
USD 74,716
|
3,352
-3.3%
|
22.29
|
USD 74,716
|
|
|
2022-03-18 |
2022-03-17 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
125,000
-8.5%
20.25
USD 2,531,250
|
125,000
-8.5%
|
20.25
|
USD 2,531,250
|
|
|
2022-03-18 |
2022-03-16 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
125,000
-7.8%
20.17
USD 2,521,250
|
125,000
-7.8%
|
20.17
|
USD 2,521,250
|
|
|
2022-03-18 |
2022-03-16 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
3,000
-1.4%
20.00
USD 60,000
|
3,000
-1.4%
|
20.00
|
USD 60,000
|
|
|
2022-03-17 |
2022-03-16 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
62,485
-2.8%
20.17
USD 1,260,322
|
62,485
-2.8%
|
20.17
|
USD 1,260,322
|
|
|
2022-03-14 |
2022-03-11 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
27,515
-1.2%
20.29
USD 558,279
|
27,515
-1.2%
|
20.29
|
USD 558,279
|
|
|
2022-02-22 |
2022-02-18 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
4,706
-0.2%
23.93
USD 112,615
|
4,706
-0.2%
|
23.93
|
USD 112,615
|
|
|
2022-02-22 |
2022-02-18 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
70,294
-3.0%
23.31
USD 1,638,553
|
70,294
-3.0%
|
23.31
|
USD 1,638,553
|
|
|
2022-02-22 |
2022-02-17 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
6,518
-0.3%
25.49
USD 166,144
|
6,518
-0.3%
|
25.49
|
USD 166,144
|
|
|
2022-02-22 |
2022-02-17 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
30,075
-1.3%
24.93
USD 749,770
|
30,075
-1.3%
|
24.93
|
USD 749,770
|
|
|
2022-02-22 |
2022-02-17 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
53,407
-2.2%
23.83
USD 1,272,689
|
53,407
-2.2%
|
23.83
|
USD 1,272,689
|
|
|
2022-02-02 |
2022-02-01 |
PS
Planned sale
|
SLAINE MASON P
Non-Executive Director
|
14,801
-0.9%
26.80
USD 396,667
|
14,801
-0.9%
|
26.80
|
USD 396,667
|
|
|
2022-02-02 |
2022-02-01 |
PS
Planned sale
|
SLAINE MASON P
Non-Executive Director
|
35,199
-2.1%
26.53
USD 933,829
|
35,199
-2.1%
|
26.53
|
USD 933,829
|
|
|
2022-01-27 |
2022-01-26 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
3,000
-1.4%
26.01
USD 78,030
|
3,000
-1.4%
|
26.01
|
USD 78,030
|
|
|
2022-01-27 |
2022-01-26 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
51,196
-2.1%
25.67
USD 1,314,201
|
51,196
-2.1%
|
25.67
|
USD 1,314,201
|
|
|
2022-01-27 |
2022-01-26 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
23,804
-0.9%
24.72
USD 588,435
|
23,804
-0.9%
|
24.72
|
USD 588,435
|
|
|
2022-01-21 |
2022-01-20 |
PS
Planned sale
|
Edge Justin
PRES., REGULATORY & ACCESS
Officer
|
5,000
-1.2%
27.50
USD 137,500
|
5,000
-1.2%
|
27.50
|
USD 137,500
|
|
|
2022-01-20 |
2022-01-18 |
PS
Planned sale
|
Traynor Richard M.
SVP AND GENERAL COUNSEL
Officer
|
5,000
-2.2%
27.44
USD 137,200
|
5,000
-2.2%
|
27.44
|
USD 137,200
|
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
SLAINE MASON P
Non-Executive Director
|
9,677
-0.6%
28.88
USD 279,472
|
9,677
-0.6%
|
28.88
|
USD 279,472
|
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
SLAINE MASON P
Non-Executive Director
|
40,323
-2.4%
28.57
USD 1,152,028
|
40,323
-2.4%
|
28.57
|
USD 1,152,028
|
|
|
2021-12-23 |
2021-12-22 |
PS
Planned sale
|
CASHMAN JAMES E III
Non-Executive Director
|
19,889
-4.1%
29.00
USD 576,781
|
19,889
-4.1%
|
29.00
|
USD 576,781
|
|
|
2021-12-23 |
2021-12-22 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
75,000
-2.9%
28.58
USD 2,143,500
|
75,000
-2.9%
|
28.58
|
USD 2,143,500
|
|
|
2021-12-21 |
2021-12-20 |
PS
Planned sale
|
Choe Jieun W.
CHIEF STRATEGY & MARKETING
Officer
|
7,500
-2.9%
28.00
USD 210,000
|
7,500
-2.9%
|
28.00
|
USD 210,000
|
|
|
2021-12-20 |
2021-12-17 |
PS
Planned sale
|
Choe Jieun W.
CHIEF STRATEGY & MARKETING
Officer
|
5,000
-1.9%
26.13
USD 130,650
|
5,000
-1.9%
|
26.13
|
USD 130,650
|
|
|
2021-12-14 |
2021-12-13 |
PS
Planned sale
|
SLAINE MASON P
Non-Executive Director
|
100
-0.0%
28.55
USD 2,855
|
100
-0.0%
|
28.55
|
USD 2,855
|
|
|
2021-12-14 |
2021-12-13 |
PS
Planned sale
|
SLAINE MASON P
Non-Executive Director
|
49,900
-2.9%
28.05
USD 1,399,695
|
49,900
-2.9%
|
28.05
|
USD 1,399,695
|
|
|
2021-12-08 |
2021-12-07 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
54,849
-2.1%
27.82
USD 1,525,899
|
54,849
-2.1%
|
27.82
|
USD 1,525,899
|
|
|
2021-12-08 |
2021-12-07 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
15,151
-0.6%
27.58
USD 417,865
|
15,151
-0.6%
|
27.58
|
USD 417,865
|
|
|
2021-12-06 |
2021-12-03 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
3,500
-0.1%
26.54
USD 92,890
|
3,500
-0.1%
|
26.54
|
USD 92,890
|
|
|
2021-12-06 |
2021-12-03 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
66,500
-2.4%
25.99
USD 1,728,335
|
66,500
-2.4%
|
25.99
|
USD 1,728,335
|
|
|
2021-11-26 |
2021-11-24 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
17,479
-0.6%
28.66
USD 500,948
|
17,479
-0.6%
|
28.66
|
USD 500,948
|
|
|
2021-11-26 |
2021-11-24 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
127,521
-4.4%
28.40
USD 3,621,596
|
127,521
-4.4%
|
28.40
|
USD 3,621,596
|
|
|
2021-11-24 |
2021-11-22 |
S
Sale
|
EQT Avatar Parent L.P.
Large shareholder
|
8,117,655
-17.8%
29.74
USD 241,427,177
|
8,117,655
-17.8%
|
29.74
|
USD 241,427,177
|
|
|
2021-11-24 |
2021-11-22 |
S
Sale
|
SLAINE MASON P
Non-Executive Director
|
376,149
-17.8%
29.74
USD 11,187,047
|
376,149
-17.8%
|
29.74
|
USD 11,187,047
|
|
|
2021-11-22 |
2021-11-19 |
PS
Planned sale
|
Choe Jieun W.
CHIEF STRATEGY & MARKETING
Officer
|
20,000
-7.1%
30.30
USD 606,000
|
20,000
-7.1%
|
30.30
|
USD 606,000
|
|
|
2021-11-22 |
2021-11-19 |
PS
Planned sale
|
Feehery William F
CHIEF EXECUTIVE OFFICER
Executive Director
|
70,000
-2.4%
30.31
USD 2,121,700
|
70,000
-2.4%
|
30.31
|
USD 2,121,700
|
|
|
2021-11-16 |
2021-11-15 |
PS
Planned sale
|
Schemick Michael Andrew
CHIEF FINANCIAL OFFICER
Officer
|
770
-0.2%
38.57
USD 29,699
|
770
-0.2%
|
38.57
|
USD 29,699
|
|
|
2021-11-16 |
2021-11-15 |
PS
Planned sale
|
Schemick Michael Andrew
CHIEF FINANCIAL OFFICER
Officer
|
65,896
-11.7%
37.83
USD 2,492,846
|
65,896
-11.7%
|
37.83
|
USD 2,492,846
|
|
